Maternal immunisation against Group B Streptococcus: A globa

Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus.

Related Keywords

United Kingdom , United States , South Africa , Gambia , Netherlands , America , Clint Pecenka , Ranju Baral , London School Of Hygiene Tropical Medicine , Sustainable Development Goal , World Bank Region , Scientific Advisory Group , Melinda Gates Foundation , World Bank , World Health Organisation , Groupb Streptococcus , Product Development For Vaccines Advisory Committee , Groupb Streprococcus , Product Characteristics , Creative Commons Attribution License , London School , Tropical Medicine , Melinda Gates , World Health , Full Value , Vaccines Assessment , Gross Domestic Product , Product Development , Vaccines Advisory Committee , United Nations World Populations Prospects , United States Dollars , Tetanus Toxoid , Defeating Meningitis , Saharan Africa , Sustainable Development , Vaccine Assessment , Vaccination And Immunization , Vaccines , Stillbirths , Economic Analysis , Vaccine Development , Cost Effectiveness Analysis , Medical Risk Factors , Preterm Birth ,